Evaluation of bacterial ghosts, cholera toxin mutant and Montanide as mucosal adjuvants/delivery systems for the nontypeable Haemophilus influenzae antigen OMP26
James L. McGrath(University of Rochester Medicine), Jennelle M. Kyd, Barbara Mayr, Allan W. Cripps(Griffith University), Werner Lubitz(Croma Pharma (Austria)), Nils Lycke(Institute for Biomedicine), Lauren O. Bakaletz(Nationwide Children's Hospital)
Griffith Research Online (Griffith University, Queensland, Australia)
January 1, 2007
Cited by 0
Related Papers
Recent progress in mucosal vaccine development: potential and limitations
|Nature reviews. Immunology|2012|781
Charge- and size-based separation of macromolecules using ultrathin silicon membranes
|Nature|2007|754
The influence of protein adsorption on nanoparticle association with cultured endothelial cells
|Biomaterials|2008|408
Non-typeable Haemophilus influenzae, an under-recognised pathogen
|The Lancet Infectious Diseases|2014|332
Evidence of <i>Staphylococcus Aureus</i> Deformation, Proliferation, and Migration in Canaliculi of Live Cortical Bone in Murine Models of Osteomyelitis
|Journal of Bone and Mineral Research|2016|264